Literature DB >> 8898944

Raf regulates positive selection.

C C O'Shea1, T Crompton, I R Rosewell, A C Hayday, M J Owen.   

Abstract

T cell development is regulated by extracellular signals that mediate cellular proliferation and differentiation via specific signal transduction pathways. To determine the importance of the mitogen-activated protein kinase (MAP kinase) pathway in thymocyte development, we analyzed transgenic mice expressing dominant negative Raf (DN Raf) and a constitutively active v-Raf under the control of the p56lck proximal promoter. DN Raf had a profound effect on T cell receptor (TCR)-mediated signaling events as assessed by the inhibition of mitogen-induced proliferation of thymocytes in vitro. Overall thymocyte numbers were decreased by at most twofold from nontransgenic littermates. Positive selection was inhibited in DN Raf transgenic mice, as evidenced by both reduced numbers of mature thymocytes and a decrease in CD8+ thymocytes in female mice doubly transgenic for DN-Raf and a class I-restricted H-Y TCR. In contrast, the differentiation of double-positive thymocytes to single-positive thymocytes was enhanced in H-YTCR transgenic mice expressing constitutively active Raf (v-Raf). Thus, Raf regulates positive selection in the thymus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898944     DOI: 10.1002/eji.1830261012

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  26 in total

Review 1.  Regulation of T cell development in the thymus.

Authors:  J Kaye
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Thymocyte apoptosis.

Authors:  Y Yang; J D Ashwell
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.

Authors:  A Sewing; B Wiseman; A C Lloyd; H Land
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

4.  Altered thymic positive selection and intracellular signals in Cbl-deficient mice.

Authors:  M Naramura; H K Kole; R J Hu; H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

5.  Costimulatory signals are required for induction of transcription factor Nur77 during negative selection of CD4(+)CD8(+) thymocytes.

Authors:  D Amsen; C Revilla Calvo; B A Osborne; A M Kruisbeek
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

6.  Control of B cell development by Ras-mediated activation of Raf.

Authors:  B M Iritani; K A Forbush; M A Farrar; R M Perlmutter
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

7.  The early proximal αβ TCR signalosome specifies thymic selection outcome through a quantitative protein interaction network.

Authors:  Steven C Neier; Alejandro Ferrer; Katelynn M Wilton; Stephen E P Smith; April M H Kelcher; Kevin D Pavelko; Jenna M Canfield; Tessa R Davis; Robert J Stiles; Zhenjun Chen; James McCluskey; Scott R Burrows; Jamie Rossjohn; Deanne M Hebrink; Eva M Carmona; Andrew H Limper; Dietmar J Kappes; Peter J Wettstein; Aaron J Johnson; Larry R Pease; Mark A Daniels; Claudia Neuhauser; Diana Gil; Adam G Schrum
Journal:  Sci Immunol       Date:  2019-02-15

8.  The transmembrane adapter protein SIT regulates thymic development and peripheral T-cell functions.

Authors:  Luca Simeoni; Vilmos Posevitz; Uwe Kölsch; Ines Meinert; Eddy Bruyns; Klaus Pfeffer; Dirk Reinhold; Burkhart Schraven
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development.

Authors:  Jane E Willoughby; Patrick S Costello; Robert H Nicolas; Nicholas J Robinson; Gordon Stamp; Fiona Powrie; Richard Treisman
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

10.  CAML regulates Bim-dependent thymocyte death.

Authors:  C E Edgar; L D Lindquist; D L McKean; A Strasser; R J Bram
Journal:  Cell Death Differ       Date:  2010-03-19       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.